FDA Issues Warning Letter to Triderma
July 24, 2024
July 24, 2024
WASHINGTON, July 24 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Genuine Virgin Aloe Corp. dba Triderma:
* * *
To: Ms. Gloria J. Vanderlaan, Chief Executive Officer, Genuine Virgin Aloe Corp dba Triderma, 1395 N. Manassero Street, Anaheim, CA 92807, United States
Dear Ms. Vanderlaan:
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, . . .
* * *
To: Ms. Gloria J. Vanderlaan, Chief Executive Officer, Genuine Virgin Aloe Corp dba Triderma, 1395 N. Manassero Street, Anaheim, CA 92807, United States
Dear Ms. Vanderlaan:
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, . . .